Serious question: What does the future hold for Astellas?

Discussion in 'Astellas' started by anonymous, Dec 16, 2017 at 4:08 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Hospital and uro have no pipeline. Oncology neither. Can you guess what future will be?
     

  2. anonymous

    anonymous Guest

    in short, it holds NO future. We lead the way in the decline of pharma.
    we deserve what we get.
     
  3. anonymous

    anonymous Guest

    I feel bad for the people left behind. This sucks. APEX is the sign of restructuring. This was the sign of mass layoffs at Pfizer and J&J. Good luck!
     
  4. anonymous

    anonymous Guest

    When is Myrbetriq going to be officially generic?
     
  5. anonymous

    anonymous Guest

  6. anonymous

    anonymous Guest


    Thank you, I’m interviewing and was confused on details. Didn’t want to take a job that would be eliminated in 6 months
     
  7. anonymous

    anonymous Guest

     
  8. anonymous

    anonymous Guest

    Technically, the Sept 2022 date is the earliest that Myrbetriq could face generic competition. There is a good chance that the real date will be sometime in 2023 (or later). The law isn't black and white, and the courts will ultimately decide when a generic manufacturer can start selling Myrbetriq.
     
  9. anonymous

    anonymous Guest

    Very true. Great place for reps to voice their opinion. Wish other parts of the company could too. Medical, specifically medical communications is led by a couple of selfish and incompetent non-leaders. They are the most superficial, position grabbing, self promoting liars. Fake exterior evil insides.
     
  10. Please let LN be the first to get her ass fired.
     
  11. anonymous

    anonymous Guest


    Maybe not the first, but certainly in the first group!
     
  12. anonymous

    anonymous Guest

    That is the only way LN will be 1st at anything.